Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on July 22, 2025
uniQure to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 22, 2025
LEXINGTON, Mass. and AMSTERDAM, July 22, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report second quarter 2025 financial results before …
Gilat Awarded Approximately $60 Million to Provide Digital Inclusion Solutions in Peru
GlobeNewswire
·
July 22, 2025
PETAH TIKVA, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Peruvian subsidiary, Gilat Perú, has …
USA Rare Earth Announces Date for Second Quarter 2025 Results and Conference Call
GlobeNewswire
·
July 22, 2025
STILLWATER, Okla., July 22, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it will release financial results for the quarterly period ended June 30, 2025, after U.S. markets close on Monday, August …
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
GlobeNewswire
·
July 22, 2025
CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on August 6, 2025 at 8:30 a.m. ET to …
ProMIS Neurosciences Announces Private Placement Financing
GlobeNewswire
·
July 22, 2025
TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded …
Health Canada Authorizes bioLytical’s iStatis Syphilis Test, Boosting Rapid Response to Rising Infections in Canada
GlobeNewswire
·
July 22, 2025
Now authorized for professional use in Canada, the iStatis Syphilis Antibody Test offers a fast, accurate, and portable solution to strengthen syphilis screening efforts nationwide. Health Canada authorizes the iStatis Syphilis Antibody Test for …
Santé Canada autorise le test de dépistage de la syphilis iStatis de bioLytical, afin de renforcer la réponse rapide à l’augmentation des infections au Canada
GlobeNewswire
·
July 22, 2025
Maintenant autorisé à une utilisation professionnelle au Canada, le test de dépistage des anticorps de la syphilis iStatis offre une solution rapide, précise et portable pour renforcer les efforts de dépistage de la syphilis dans tout le pays. Santé Canada …
FACIA Reports 100% Accuracy in Deepfake Detection Across Industry Datasets
GlobeNewswire
·
July 22, 2025
LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- FACIA, a global leader in facial biometric technology, announced that its deepfake detection system has achieved 100% accuracy on multiple industry datasets, including Meta’s Deepfake Detection Challenge Dataset ( …
Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation
GlobeNewswire
·
July 22, 2025
PRESS RELEASE Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation Novel antibody, potravitug, demonstrates high neutralization of all BKPyV serotypes with potential to transform treatment …
Dataprana Announces Official Launch of 30MW Immersion-Cooled Data Center in La Marque, Texas
GlobeNewswire
·
July 22, 2025
LA MARQUE, Texas, July 22, 2025 (GLOBE NEWSWIRE) -- Dataprana, Inc. (“Dataprana”), a US-based data center developer and operator focused on high-performance, energy-intensive infrastructure for digital asset mining and AI workloads, has officially launched …
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not intend to …
Avalyn Completes Oversubscribed $100 Million Series D Financing to Further Advance Clinical Development of Novel Inhaled Therapies for Pulmonary Fibrosis
GlobeNewswire
·
July 22, 2025
Financing led by Suvretta Capital Management and SR One with participation from 16 additional healthcare investors Proceeds will support key clinical milestones across all of Avalyn’s pipeline programs CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- …
ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation
GlobeNewswire
·
July 22, 2025
HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility’s Peak Load Reduction program, a …
Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors
GlobeNewswire
·
July 22, 2025
MEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Morphoceuticals Inc., a TechBio company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of industry veteran Roger Pomerantz, MD, as Chairman …
CGS Announces Corporate Restructuring; Forms Four Independent Companies to Accelerate Growth
GlobeNewswire
·
July 22, 2025
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Computer Generated Solutions, Inc. (CGS), a global provider of software applications, enterprise learning, customer experience and business process outsourcing services, today announced that the company has …
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
GlobeNewswire
·
July 22, 2025
WARREN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
GlobeNewswire
·
July 22, 2025
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in July …
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
GlobeNewswire
·
July 22, 2025
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ("Life Molecular"), a …
HydroGraph Confirms No Undisclosed Material Information or Change in Operations
GlobeNewswire
·
July 22, 2025
VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- At the request of CIRO, HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) wishes to confirm that there is no undisclosed material information at this time. …
OncoC4 Doses First Patient with Potential Best-in-Class PD-1/VEGF Bispecific Antibody AI-081 in Phase 2 Portion of BIPAVE-001 Trial for Advanced Solid Tumors in US
GlobeNewswire
·
July 22, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the first patient has been dosed in the Phase 2 portion of the Phase 1/2 BIPAVE-001 trial ( …